TRL.TO News 0.63 Trimel Pharmaceuticals Corp (TRL.TO)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Trimel Pharmaceuticals Corp (TRL.TO) 0.63 $TRL.TO

Trimel Reports Fourth Quarter and Full Year 2013 Financial Results
Marketwire - Wed Mar 05, 6:34PM CST
Trimel Pharmaceuticals Corporation (TSX: TRL) today provided an overview of its corporate accomplishments and reported financial results for the three and twelve month periods ended December 31, 2013.

Trimel to Report Financial Results for 2013 and Host Conference Call to Update Investors
Marketwire - Thu Feb 27, 3:46PM CST
Trimel Pharmaceuticals Corporation (TSX: TRL) will report its financial results for the 3 month and 12 month periods ended December 31, 2013 on Wednesday, March 5th 2014 after market close.

Trimel Announces Closing of $10.5 Million Private Placement of Common Shares
Marketwire - Fri Feb 21, 2:46PM CST
Trimel Pharmaceuticals Corporation (TSX: TRL) announced today that the previously disclosed private placement of 14,829,676 common shares ("Common Shares", in aggregate, to First Generation Capital Inc. and West Face Long Term Opportunities Global Master L.P. for total gross proceeds of $10,543,000 has been completed.

IIROC Trade Resumption - TRL
CNW Group - Thu Feb 20, 7:25AM CST
Trading resumes in:

IIROC Trading Halt - TRL
CNW Group - Wed Feb 19, 3:01PM CST
The following issues have been halted by IIROC:

Trimel Announces $10.5 Million Private Placement of Common Shares
Marketwire - Wed Feb 19, 2:38PM CST
Trimel Pharmaceuticals Corporation (TSX: TRL) announced today that it has entered into subscription agreements in connection with a private placement of 14,829,676 common shares ("Common Shares" for aggregate gross proceeds in the amount of $10,543,900. The issue price of the Common Shares will be $0.711 per share, equal to the "market price" of the Common Shares as of the date of acceptance of the applicable subscriptions (as calculated in accordance with the rules of the Toronto Stock Exchange ("TSX"). The Common Shares will be subject to a hold period under applicable securities laws, which will expire four months plus one day from the date of closing.

Trimel Announces Appointment of New Vice President, Scientific Affairs
Marketwire - Thu Jan 23, 4:05PM CST
Trimel Pharmaceuticals Corporation (TSX: TRL) is pleased to announce the appointment of Dr. Nathan Bryson to the position of Vice President, Scientific Affairs. Dr. Bryson will replace Mr. Wayne Kreppner who has elected to pursue other opportunities. Dr. Bryson will be responsible for all areas of the Company's research and development activities as well as leading the clinical, regulatory affairs, and manufacturing functions.

Trimel Provides Update Regarding CompleoTRT(TM) FDA Review
Marketwire - Fri Jan 17, 6:56AM CST
Trimel Pharmaceuticals Corporation (TSX: TRL) today announced that the United States Food and Drug Administration ("FDA" has decided to extend the Prescription Drug User Fee Act (PDUFA) target action date for the CompleoTRT(TM) new drug application ("NDA" from February 28, 2014 to May 28, 2014. This will provide the FDA with the required time for a full review of the submission in light of the previously announced decision by the Company to amend its proposed label.

Trimel Announces Appointment of Tom Rossi to Its Board of Directors
Marketwire - Thu Jan 16, 4:08PM CST
Trimel Pharmaceuticals Corporation (TSX: TRL) today announced the appointment of Mr. Tom Rossi, the company's President and Chief Executive Officer, to its Board of Directors, effective January 21, 2014.

Trimel Completes Enrollment of Tefina(TM) Ambulatory Study
Marketwire - Tue Jan 14, 4:00PM CST
Trimel Pharmaceuticals Corporation (TSX: TRL) is pleased to announce that it has completed enrollment of its ongoing Tefina(TM) Phase II clinical trial. Tefina(TM) is being developed and clinically tested as a possible treatment for women suffering from Female Orgasmic Disorder.

Trimel Announces Retirement of Chair and Appointment of New Chair
Marketwire - Fri Jan 10, 4:05PM CST
Trimel Pharmaceuticals Corporation (TSX: TRL) today announced the retirement of Mr. Bruce Brydon as Chair of the Board of Directors and as a Director.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Mercari and Suruga-ya Forge U.S. Venture for Culture

Updated Category News Views 0

Japanese Pop Culture Gears Up for US Market Surge Alright, folks, what we’ve got here is another bold move in the cross-border e-commerce game. Mercari and Suruga-ya are teaming up to establish a joint venture over in the U.S. The goal? To further capitalize on the growing appetite for Japanese entertainment and hobby goods among us all stateside. Now, it’s no secret...

Continue Reading
Tuya Smart: AI Powers New Energy Wave at COP31

Updated Category News Views 55

Tuya Smart's Bold Move at COP31 Tuya Smart, a name you don't want to ignore in the world of energy innovation, made a commanding appearance at COP31. Their message was loud and clear: as the climate gets harsher, they're not just sitting around waiting for the next storm. They're arming households with AI-driven solutions. AI-Powered Energy Management Takes Center Stage...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 229

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
Kayla Harrison Dominates UFC 334, Earns Big Win

Updated Category News Views 64

Kicking off UFC 334 with a bang, Kayla Harrison didn't just step into the Octagon—she bulldozed her way through Amanda Nunes to retain her Women's Bantamweight Championship. This showdown didn't just electrify New York's Madison Square Garden, it shook the entire MMA landscape. Harrison, the face of Monster Energy's athlete roster, wasn't content with just defending her...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 275

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
Hanwha Power Seals Second FSRU Conversion Deal

Updated Category News Views 71

Riding the FSRU Wave with Hanwha Power Alright, we've got Hanwha Power step-dancing onto the LNG stage with its second splash into the FSRU (Floating Storage and Regasification Unit) conversion gig. Partnering up with Energos Infrastructure, these guys are making serious waves in the energy market by transforming what's pretty much a regular ship into a floating gas...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 218

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 175

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 407

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 178

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading

Top 5 Most Recently Viewed Articles

Balavant Insurance Group Welcomes John Jankowski as CIO

Updated Category News Views 317

Leadership Appointment at Balavant Insurance Group Balavant Insurance Group has made a significant move by appointing John Jankowski as its new Chief Information Officer. This announcement marks a pivotal moment for the company, known for its focus on technological advancement and innovative insurance solutions. Strategic Role of the Chief Information Officer In his role,...

Continue Reading
Exploring the Growth of the Industrial Absorbent Sector

Updated Category News Views 245

Understanding the Industrial Absorbent Market Dynamics The industrial absorbent market is poised for remarkable growth, expected to reach $5.50 billion by 2031. This growth trajectory aligns with a compound annual growth rate (CAGR) of 4.3%. The increase in market size is largely driven by the rising usage of absorbents across various industries in response to...

Continue Reading
ChoiceOne Financial Services Achieves Successful Bank Merger

Updated Category News Views 147

Successful Bank Merger by ChoiceOne Financial Services ChoiceOne Financial Services, Inc. (NASDAQ: COFS), the parent company of ChoiceOne Bank, has achieved a significant milestone by completing the consolidation of The State Bank into ChoiceOne Bank. This strategic move empowers the strength of ChoiceOne, further enhancing its service capabilities and market presence. A...

Continue Reading
Danantara Indonesia and INA Forge Nickel Investment Alliance with Eramet

Updated Category News Views 443

Strategic Collaboration for Nickel Development In a significant move to bolster the nickel downstream industry, partners including Danantara Indonesia and the Indonesia Investment Authority (INA) have officially signed a Memorandum of Understanding (MoU) with the prominent French mining company, Eramet. This collaboration aims to create an extensive investment platform...

Continue Reading
Full Moon Bar-B-Que's Generous Initiative for Local Kids

Updated Category News Views 180

Full Moon Bar-B-Que's Generosity In a heartwarming gesture, Full Moon Bar-B-Que has made a significant impact on the community by contributing $200,000 worth of backpacks and school supplies. Their ongoing commitment through the Backpack Blessings program is not just about donations; it's about nurturing and empowering local children who need support the most. Supporting...

Continue Reading